ADJUVANCE TECHNOLOGIES INC
formerly Adjuvance TechnologiesLincoln, United States · Founded 2017 · $23.0M raised
- Headquarters
- Lincoln, Nebraska
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- adjuvancetechnologies.org
- Total Funding
- $23.0M
- Last Round
- $1.5M GrantMay 2020
- Rounds
- 6
About
Adjuvance Technologies is a Lincoln, Nebraska biopharmaceutical company developing next-generation semi-synthetic saponin adjuvants to improve vaccine efficacy and duration. The company licenses its proprietary adjuvant platform to vaccine developers globally and has collaborated with Memorial Sloan-Kettering Cancer Center.
Summary
ADJUVANCE TECHNOLOGIES INC is a Biotech company based in Lincoln, United States, founded in 2017. It has raised $23.0M in total across 6 rounds, most recently a $1.5M Grant round in May 2020. Investors include National Institutes of Health, Morningside Group and 5Y Capital.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2020
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...